Literature DB >> 26059750

The growth hormone receptor.

Michael J Waters1.   

Abstract

Once thought to be present only in liver, muscle and adipose tissue, the GH receptor is now known to be ubiquitously distributed, in accord with the many pleiotropic actions of GH. These include the regulation of metabolism, postnatal growth, cognition, immune, cardiac and renal systems and gut function. GH exerts these actions primarily through alterations in gene expression, initiated by activation of its membrane receptor and the resultant activation of the associated JAK2 (Janus kinase 2) and Src family kinases. Receptor activation involves hormone initiated movements within a receptor homodimer, rather than simple receptor dimerization. We have shown that binding of the hormone realigns the orientation of the two receptors both by relative rotation and by closer apposition just above the cell membrane. This is a consequence of the asymmetric placement of the binding sites on the hormone. Binding results in a conversion of parallel receptor transmembrane domains into a rotated crossover orientation, which produces separation of the lower part of the transmembrane helices. Because the JAK2 is bound to the Box1 motif proximal to the inner membrane, receptor activation results in separation of the two associated JAK2s, and in particular the removal of the inhibitory pseudokinase domain from the kinase domain of the other JAK2 (and vice versa). This brings the two kinase domains into position for trans-activation and initiates tyrosine phosphorylation of the receptor cytoplasmic domain and other substrates such as STAT5, the key transcription factor mediating most genomic actions of GH. There are a limited number of genomic actions initiated by the Src kinase family member which also associates with the upper cytoplasmic domain of the receptor, including important immune regulatory actions to dampen exuberant innate immune activation of cells involved in transplant rejection. These findings offer insights for developing specific receptor antagonists which may be valuable in cancer therapy. Crown
Copyright © 2015. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  JAK2; Mechanism; Receptor structure; STAT5; Src

Mesh:

Substances:

Year:  2015        PMID: 26059750     DOI: 10.1016/j.ghir.2015.06.001

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  35 in total

1.  Defining human insulin-like growth factor I gene regulation.

Authors:  Aditi Mukherjee; Damir Alzhanov; Peter Rotwein
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-12       Impact factor: 4.310

2.  Characterizing the complexity of Australian marsupial insulin-like growth factor 1 genes.

Authors:  Peter Rotwein
Journal:  Mol Cell Endocrinol       Date:  2019-03-11       Impact factor: 4.102

Review 3.  Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.

Authors:  Xuehong Dong; Lei Su; Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2022-08-24       Impact factor: 5.430

4.  Constitutively Active STAT5b Feminizes Mouse Liver Gene Expression.

Authors:  Dana Lau-Corona; Hong Ma; Cameron Vergato; Andre Sarmento-Cabral; Mercedes Del Rio-Moreno; Rhonda D Kineman; David J Waxman
Journal:  Endocrinology       Date:  2022-05-01       Impact factor: 5.051

5.  STAT5 Regulation of Sex-Dependent Hepatic CpG Methylation at Distal Regulatory Elements Mapping to Sex-Biased Genes.

Authors:  Pengying Hao; David J Waxman
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

Review 6.  Regulation of gene expression by growth hormone.

Authors:  Peter Rotwein
Journal:  Mol Cell Endocrinol       Date:  2020-03-06       Impact factor: 4.102

Review 7.  Mouse models of growth hormone insensitivity.

Authors:  Jonathan Young; Stephen Bell; Yanrong Qian; Caroline Hyman; Darlene E Berryman
Journal:  Rev Endocr Metab Disord       Date:  2020-10-10       Impact factor: 6.514

Review 8.  Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes.

Authors:  Natalia N Singh; Shaine Hoffman; Prabhakara P Reddi; Ravindra N Singh
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-05       Impact factor: 5.187

9.  The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.

Authors:  Rand Shibel; Rive Sarfstein; Karthik Nagaraj; Lena Lapkina-Gendler; Zvi Laron; Manisha Dixit; Shoshana Yakar; Haim Werner
Journal:  Cells       Date:  2021-06-12       Impact factor: 6.600

10.  Order and disorder-An integrative structure of the full-length human growth hormone receptor.

Authors:  Noah Kassem; Raul Araya-Secchi; Katrine Bugge; Abigail Barclay; Helena Steinocher; Adree Khondker; Yong Wang; Aneta J Lenard; Jochen Bürck; Cagla Sahin; Anne S Ulrich; Michael Landreh; Martin Cramer Pedersen; Maikel C Rheinstädter; Per Amstrup Pedersen; Kresten Lindorff-Larsen; Lise Arleth; Birthe B Kragelund
Journal:  Sci Adv       Date:  2021-06-30       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.